Investigator Perspectives on the Role of Bispecific Antibodies in the Management of Lymphoma 

RTP Live from Chicago: Investigator Perspectives on the Role of Bispecific Antibodies in the Management of Lymphoma
Proceedings from a webinar on June 4, 2024, held in conjunction with the ASCO 2024 Annual Meeting and moderated by Dr Neil Love. Featuring perspectives from Dr Joshua Brody, Dr Ian W Flinn and Dr Tycel Phillips. Published July 12, 2024.
Topics:
• Introduction: CD3 Bispecific Antibodies in the Community Oncology Setting (0:00)
• Integration of Bispecific Antibody Therapy into the Management of Diffuse Large B-Cell Lymphoma - Dr Phillips (18:13)
• Current and Future Role of Bispecific Antibodies in Follicular Lymphoma and Other B-Cell Lymphomas - Dr Flinn (41:20)
• Tolerability and Other Practical Considerations with the Use of Bispecific Antibody Therapy - Dr Brody (50:49)
The entire program, slides, CME information, and, select publications:
www.researchtopractice.com/AS...

Наука